hantaan
viru
htnv
major
agent
caus
hemorrhag
fever
renal
syndrom
hfr
although
pathogenesi
hfr
unclear
report
suggest
abund
product
proinflammatori
cytokin
uncontrol
inflammatori
respons
may
contribut
develop
hfr
one
cytokin
found
involv
pathogenesi
mani
viru
infecti
diseas
howev
role
pathogenesi
hfr
molecular
regul
mechan
htnv
infect
remain
unknown
studi
report
express
highli
hfr
patient
sera
elev
posit
correl
sever
hfr
find
htnv
singlestrand
rna
viru
act
doublestrand
rna
activ
rigi
signal
pathway
downstream
transcript
factor
pathway
nfb
bind
directli
promot
express
increas
result
may
help
better
understand
role
develop
hfr
may
provid
novel
insight
immun
respons
htnv
infect
hantaan
viru
htnv
member
envelop
bunyavirida
famili
character
tripartit
singlestrand
rna
genom
neg
polar
larg
l
segment
encod
viral
rnadepend
rna
polymeras
rdrp
medium
segment
encod
two
surfac
glycoprotein
gn
gc
small
segment
encod
nucleocapsid
protein
np
htnv
could
caus
sever
lethal
hemorrhag
fever
renal
syndrom
hfr
human
present
pathogenesi
hfr
still
unclear
previou
report
suggest
cytokin
storm
addit
immun
respons
complement
activ
platelet
dysfunct
may
potenti
mechan
hfr
pathogenesi
inflammatori
cytokineschemokin
produc
htnv
infect
repres
doubleedg
sword
one
hand
contribut
viral
elimin
induc
amplifi
innat
effector
function
antigen
present
viral
epitop
cell
hand
properli
regul
inflammatori
cytokineschemokin
may
facilit
immunopatholog
process
hfr
screen
panel
cytokin
express
use
luminex
found
serum
hfr
patient
mosthighlyexpress
cytokin
see
tabl
supplementari
materi
avail
onlin
http
induc
member
cxc
chemokin
mainli
secret
endotheli
cell
epitheli
cell
keratinocyt
bind
receptor
induc
chemotaxi
mediat
inflamm
apoptosi
cell
growth
inhibit
angiostasi
accumul
data
indic
play
import
role
mani
viru
infecti
diseas
infect
hepat
viru
b
hbv
hepat
viru
c
hcv
hiv
influenza
viru
virus
elev
level
found
correl
develop
sever
infecti
diseas
studi
regul
mechan
product
signal
pathway
document
contribut
regul
express
includ
jakstat
pathway
pathway
pathway
transcript
factor
like
nfb
also
prove
bind
promot
although
geimonen
et
al
report
htnv
induc
express
huvec
littl
known
molecular
regul
mechan
htnvinduc
product
better
understand
regul
mechan
product
infecti
diseas
might
help
us
develop
new
therapeut
intervent
human
diseas
studi
quantifi
serum
level
hfr
patient
differ
sever
differ
diseas
stage
analyz
relationship
diseas
severityind
paramet
vivo
explor
underli
regul
mechan
express
vitro
htnv
infect
studi
approv
institut
review
board
fourth
militari
medic
univers
written
inform
consent
obtain
directli
adult
subject
children
inform
consent
given
guardian
collect
sampl
subsequ
analysi
collect
enrol
studi
hospit
patient
htnv
infect
tangdu
hospit
fourth
militari
medic
univers
xian
china
clinic
diagnosi
hfr
confirm
detect
igm
antibodi
htnv
patient
serum
specimen
thirtysix
healthi
donor
includ
studi
normal
control
serum
sampl
peripher
blood
sampl
collect
store
previous
describ
base
classic
defin
stage
hfr
name
febril
stage
hypotens
stage
oligur
stage
polyur
stage
convalesc
stage
classifi
hfr
patient
studi
acut
phase
includ
febril
hypotens
oligur
stage
convalesc
phase
includ
diuret
convalesc
stage
plasma
viral
load
import
indic
diseas
sever
determin
lab
limit
detect
viral
load
group
viral
load
baselin
copiesml
human
umbil
vein
endotheli
cell
huvec
prepar
method
describ
cultur
huvec
grown
fibronectinco
plate
millipor
usa
maintain
egm
lonza
usa
supplement
fetal
bovin
serum
paa
austria
iu
penicillinml
g
streptomycinml
use
passag
htnv
strain
propag
vero
cell
supernat
collect
cell
cultur
day
postinfect
clear
cell
debri
centrifug
filtrat
filter
stock
htnv
aliquot
frozen
c
mock
htnv
control
prepar
subject
htnv
co
radiat
gy
infect
viru
allow
adsorb
huvec
multipl
infect
moi
approxim
serumfre
egm
mainten
medium
h
c
cell
wash
afterward
incub
egm
growth
medium
fb
proport
infect
huvec
test
use
immunofluoresc
h
postinfect
huvec
express
viral
nucleocapsid
protein
cytoplasm
total
rna
huvec
extract
use
trizol
invitrogen
accord
manufactur
protocol
g
use
cdna
synthesi
takara
japan
quantit
analysi
mrna
express
done
quantit
realtim
pcr
use
sybr
green
detect
method
specif
primer
gene
shown
support
inform
tabl
reaction
analyz
use
biorad
system
realtim
system
delta
ct
method
use
calcul
gene
interest
gene
normal
housekeep
gene
gapdh
present
copi
normal
medium
control
huvec
studi
seri
promot
construct
prepar
primer
shown
support
inform
tabl
follow
previou
report
point
mutat
two
nfb
site
gener
construct
indic
dna
sequenc
result
show
plasmid
construct
success
huvec
plate
plate
confluenc
cell
transfect
g
promot
report
construct
ng
prltk
plasmid
use
lipofectamin
lipo
invitrogen
usa
manufactur
protocol
fortyeight
hour
later
luciferas
activ
sampl
detect
dualluciferas
report
assay
system
promega
usa
accord
manufactur
instruct
transfect
effici
normal
renilla
luciferas
activ
data
analys
vector
control
set
rna
interfer
specif
knock
rigi
seri
doublestrand
small
interf
rna
synthes
gene
pharma
shanghai
china
sequenc
shown
support
inform
tabl
transfect
sirna
huvec
perform
use
lipo
follow
manufactur
protocol
valid
effici
sirna
mediat
inflamm
identifi
determin
mrna
protein
level
correspond
target
gene
transfect
sirna
mock
vector
huvec
amount
present
hfr
patient
sera
cultur
supernat
determin
use
specif
mous
antihuman
elisa
kit
bd
bioscienc
usa
accord
manufactur
instruct
total
protein
nuclear
protein
cytoplasm
protein
prepar
previous
describ
separ
stack
gel
sdspage
separ
gel
trisglycin
system
transfer
onto
nitrocellulos
membran
millipor
usa
membran
block
skim
milk
probe
overnight
c
antibodi
specif
respect
flag
tag
sigma
usa
epitom
usa
rigi
pi
b
pikk
tubulin
histon
cell
signal
technolog
usa
gapdh
ambion
usa
membran
wash
incub
hrpconjug
goat
antimous
antibodi
hrpconjug
goat
antirabbit
antibodi
pierc
usa
wash
membran
blot
develop
use
electrochemiluminesc
alpha
innotech
usa
nuclear
extract
prepar
previous
describ
huvec
infect
htnv
h
h
respect
biotinlabel
oligonucleotid
synthes
follow
sequenc
site
isr
site
super
shift
assay
perform
addit
antibodi
cell
signal
technolog
usa
antibodi
antibodi
bind
reaction
specif
proteindna
interact
confirm
unlabel
competit
probe
sequenc
mutat
probe
mutat
probe
chip
assay
conduct
use
commerci
chip
assay
kit
upstat
biotechnolog
usa
briefli
huvec
infect
htnv
h
crosslink
use
formaldehyd
rt
min
wash
cold
pb
cell
scrape
conic
tube
sonic
shear
chromatin
sonic
chromatin
incub
antibodi
antibodi
antibodi
overnight
c
gentli
shake
normal
mous
igg
set
isotyp
control
antirna
polymeras
set
posit
control
dnachromatinantibodi
complex
collect
protein
g
agaros
bead
afterward
dna
purifi
subject
pcr
amplif
use
follow
primer
flank
site
isr
site
promot
respect
flow
cytometri
fcm
assay
pbmc
hfr
isol
resuspend
concentr
cellsml
flow
buffer
pb
fc
fc
receptor
block
addit
normal
goat
serum
cell
stain
minut
c
monoclon
antibodi
allophycocyanin
apc
conjug
fluorescein
isothiocyan
fitc
conjug
purchas
bd
bioscienc
isotyp
control
apcconjug
fitcconjug
mous
purchas
ebiosci
cell
wash
twice
flow
buffer
l
formalin
ad
fix
cell
minimum
cell
acquir
bd
fac
calibur
flow
cytomet
beckman
coulter
fullerton
ca
analyz
use
flowjo
softwar
treestar
ashland
graphpad
softwar
statist
signific
determin
use
oneway
anova
spearman
correl
test
use
test
correl
concentr
clinic
paramet
valu
less
consid
statist
signific
correl
hfr
sever
mean
level
hfr
patient
time
higher
normal
control
versu
figur
content
acut
phase
higher
convalesc
phase
hfr
patient
level
acut
phase
convalesc
phase
hfr
patient
significantli
higher
compar
normal
control
figur
b
spearman
correl
analysi
show
increas
level
correl
increas
bun
crea
wbc
decreas
plt
count
hfr
patient
figur
c
level
viral
load
copiesml
group
significantli
higher
viral
load
copiesml
group
figur
flow
cytometri
analysi
show
express
receptor
subset
increas
acut
phase
hfr
figur
percentag
cell
subset
pbmc
increas
normal
control
hfr
patient
acut
phase
went
back
hfr
patient
convalesc
phase
figur
b
valu
patient
viral
load
copiesml
signific
higher
level
viral
load
copiesml
statist
differ
normal
control
hfr
patient
acut
phase
hfr
patient
acut
phase
patient
convalesc
phase
pathway
elisa
detect
demonstr
secret
robust
huvec
transfect
gml
poli
c
infect
htnv
figur
realtim
pcr
result
suggest
rigi
sensor
viral
dsrna
upregul
htnv
infect
sensor
ssrna
remain
unchang
figur
b
protein
level
rigi
elev
extens
infect
durat
figur
c
transfect
sirigi
respect
huvec
demonstr
knock
dsrna
sensor
also
cut
express
level
induc
htnv
infect
figur
schemat
diagram
fulllength
truncat
mutat
promot
construct
shown
figur
measur
luciferas
activ
h
transfect
found
delet
nt
nt
contain
two
nfb
site
one
isr
site
significantli
reduc
transcript
activ
figur
b
experi
repeat
three
time
mrna
data
gener
three
independ
experi
three
independ
huvec
donor
data
mean
se
htnv
infect
poli
c
treat
versu
medium
treat
cell
sirna
specif
rigi
versu
sinc
treat
cell
respect
mutat
two
nfb
site
show
mutat
bind
site
effect
reduc
activ
promot
figur
c
realtim
pcr
analysi
htnvinfect
huvec
model
show
increas
markedli
htnv
infect
poli
c
transfect
figur
knockdown
htnvinfect
huvec
impair
induct
figur
e
promot
htnv
infect
transloc
cytosol
nucleu
htnv
infect
figur
densitometr
analysi
wb
result
show
ratio
protein
level
rel
respect
load
control
tubulin
histon
figur
b
western
blot
analysi
found
phosphoryl
ikk
b
could
detect
h
post
rel
protein
level
infect
pi
h
pi
figur
c
emsa
examin
confirm
bind
directli
promot
region
posit
mobil
shift
bind
oligonucleotid
observ
oligonucleotid
incub
nuclear
extract
htnvinfect
h
pi
mock
virusinfect
medium
cultur
treat
huvec
figur
incub
oligonucleotidenuclear
complex
respect
antibodi
prior
gel
resolut
super
shift
band
confirm
observ
shift
result
bind
figur
chip
examin
prove
transcript
factor
bound
directli
promot
region
use
dna
isol
htnv
infect
cell
lysat
templat
dna
fragment
contain
nfb
site
dna
fragment
contain
isr
site
amplifi
presenc
antibodi
seen
mock
viru
infect
group
presenc
control
antibodi
figur
e
vital
role
pathogenesi
report
mani
viru
infecti
diseas
though
pengpeng
ip
fang
liao
found
could
resist
dengu
viru
denv
infect
mice
suscept
mice
denv
infect
enhanc
mani
studi
report
high
valu
level
could
use
biomark
diseas
progress
vivo
studi
show
elev
level
contribut
tissu
damag
contradictori
find
role
either
protect
promot
infect
may
depend
host
immun
statu
genet
background
studi
found
serum
level
hfr
patient
substanti
higher
correspond
level
healthi
donor
figur
content
acut
phase
hfr
time
higher
convalesc
phase
figur
b
importantli
elev
level
correl
significantli
hfr
severityind
clinic
paramet
figur
c
higher
level
higher
viral
load
group
copiesml
good
proof
product
correl
replic
htnv
figur
signal
axi
recruit
virusspecif
cell
inflammatori
site
promot
viral
clearanc
viru
infect
analys
membran
express
level
cell
nk
cell
monocyt
data
shown
reveal
level
increas
subset
pbmc
isol
hfr
patient
figur
result
suggest
increas
level
acut
phase
hfr
may
recruit
cell
monocyt
recruit
monocyt
may
produc
excess
cytokin
involv
cytokin
storm
presumpt
consist
find
cheung
et
al
studi
sarscoronaviru
find
indic
elev
level
hfr
patient
may
serv
biomark
hfr
develop
sinc
proper
anim
model
hfr
yet
testifi
protect
effect
antagonist
signal
axi
htnv
infect
vivo
jakstat
signal
pathway
report
involv
regul
viru
infecti
diseas
hiv
hbv
influenza
mechan
induct
htnv
infect
still
unknown
studi
result
transfect
poli
c
suggest
could
induc
dsrna
may
replic
intermedi
gener
htnv
replic
figur
indic
figur
mock
virus
lose
abil
replic
fail
activ
express
transfect
also
demonstr
dsrna
rather
ssrna
induc
product
dsrna
sensor
rigi
activ
htnv
infect
therefor
may
contribut
gener
ssrna
sensor
activ
figur
c
sundstrom
et
al
report
htnv
infect
rather
main
downstream
transcript
factor
regul
cytokin
product
explain
direct
correl
transcript
factor
product
htnv
infect
result
chip
emsa
demonstr
activ
htnv
infect
bind
directli
promot
huvec
figur
understand
regul
cytokineschemokin
receptor
htnv
infect
might
provid
novel
therapeut
target
hfr
studi
found
content
kda
hfr
patient
serum
drop
normal
level
hemodialysi
treatment
data
shown
current
treatment
hfr
often
limit
administr
ribavirin
primari
support
patient
suffer
sever
critic
hfr
treat
hemodialysi
remov
low
molecular
weight
protein
cytokin
chemokin
hemodialysi
seriou
side
effect
bleed
hypotens
infect
anemia
combin
antivir
anticytokineschemokin
therapi
may
better
therapeut
approach
hantaviru
infect
report
contend
htnv
member
neg
ssrna
produc
undetect
amount
dsrna
infect
present
innat
immun
activ
htnv
infect
remain
subject
much
debat
focu
whether
dsrna
like
structur
produc
replic
process
htnv
infect
disagr
may
due
differ
cell
line
use
respect
studi
clinic
patholog
find
shown
pathogen
hantavirus
specif
target
endotheli
cell
infect
accordingli
studi
use
huvec
model
studi
still
need
hantavir
rna
structur
trigger
innat
immun
activ
vivo
interact
rigi
unknown
rna
sensor
